小鼠血小板生成受造血龛S1P释放抑制,而非血S1P感知促进
该研究在小鼠中重新审视S1P在血小板生物学中的作用,发现血管S1P梯度缺失或巨核细胞S1pr1缺失均不降低血小板计数,且成熟巨核细胞原位检测不到S1P1表达和信号。相反,S1P通过S1P1限制巨核细胞生成,异常分泌时还可通过S1P2抑制血小板生成。
要点
- 血管S1P梯度缺失或巨核细胞S1pr1缺失不降低小鼠血小板计数。
- 成熟巨核细胞原位检测不到S1P1表达和信号,S1pr1缺失不影响血小板聚集或铺展。
- S1P通过S1P1限制巨核细胞生成,异常分泌时通过S1P2抑制血小板生成。
核心结论
- S1P1在促进血小板生成或活化中无关键作用,S1P反而通过S1P1限制巨核细胞生成,异常分泌时通过S1P2抑制血小板生成。
研究设计与样本
- 小鼠研究,通过损伤血浆S1P供应或间质液S1P降解消除血管S1P梯度,以及在巨核细胞中条件性删除S1pr1。
主要发现
- 血管S1P梯度消除或巨核细胞S1pr1缺失时,血小板计数未见降低。
- 成熟巨核细胞原位检测不到S1P1表达和信号,巨核细胞S1pr1缺失不影响血小板聚集或铺展。
- 在造血祖细胞中诱导S1pr1缺失后,血小板计数显著升高。
- 全身Sphk2缺陷伴血小板减少,但巨核细胞限制性Sphk2缺失未重现,且联合删除Sphk1或S1pr2可逆转。
临床怎么用
- 与临床观察一致,S1P通路调节剂(包括芬戈莫德)使用未与出血或血栓风险相关。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The bioactive lipid mediator sphingosine 1-phosphate (S1P) was recently assigned critical roles in platelet biology: whereas S1P1 receptor-mediated S1P gradient sensing was reported to be essential for directing proplatelet extensions from megakaryocytes (MKs) toward bone marrow sinusoids, MK sphingosine kinase 2 (Sphk2)-derived S1P was reported to further promote platelet shedding through receptor-independent intracellular actions, and platelet aggregation through S1P1 Yet clinical use of S1P pathway modulators including fingolimod has not been associated with risk of bleeding or thrombosis. We therefore revisited the role of S1P in platelet biology in mice. Surprisingly, no reduction in platelet counts was observed when the vascular S1P gradient was ablated by impairing S1P provision to plasma or S1P degradation in interstitial fluids, nor when gradient sensing was impaired by S1pr1 deletion selectively in MKs. Moreover, S1P1 expression and signaling were both undetectable in mature MKs in situ, and MK S1pr1 deletion did not affect platelet aggregation or spreading. When S1pr1 deletion was induced in hematopoietic progenitor cells, platelet counts were instead significantly elevated. Isolated global Sphk2 deficiency was associated with thrombocytopenia, but this was not replicated by MK-restricted Sphk2 deletion and was reversed by compound deletion of either Sphk1 or S1pr2, suggesting that this phenotype arises from increased S1P export and S1P2 activation secondary to redistribution of sphingosine to Sphk1. Consistent with clinical observations, we thus observe no essential role for S1P1 in facilitating platelet production or activation. Instead, S1P restricts megakaryopoiesis through S1P1, and can further suppress thrombopoiesis through S1P2 when aberrantly secreted in the hematopoietic niche.
引用
- Niazi H, Zoghdani N, Couty L, et al. Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. Blood Adv. 2019. PMID: 31171507. doi:10.1182/bloodadvances.2019031948
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。